Capital Asset Advisory Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$255K Sell
798
-111
-12% -$36.5K 0.01% 258
2025
Q4
$337K Buy
+909
New +$307K 0.01% 220
2024
Q4
Sell
-459
Closed -$225K 316
2024
Q3
$225K Sell
459
-5
-1% -$2.67K 0.01% 299
2024
Q2
$246K Buy
+464
New +$245K 0.01% 273

Other funds holding ELV

Capital Asset Advisory Services's ELV Position: Q1 2026 in Review

Capital Asset Advisory Services reduced its Elevance Health (ELV) stake by 12% in Q1 2026, selling an estimated $36.5K and leaving 798 shares worth $255K. The position accounts for 0.01% of the portfolio, ranked #258.

Capital Asset Advisory Services first reported a position in ELV in Q2 2024 and has held it in 4 quarters since. The position peaked at $337K in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Capital Asset Advisory Services held 798 shares of Elevance Health worth $255K as of Q1 2026.
  • Capital Asset Advisory Services sold 111 Elevance Health shares in Q1 2026, an estimated $36.5K.
  • Elevance Health made up 0.01% of Capital Asset Advisory Services's portfolio in Q1 2026, its #258 holding.
  • Capital Asset Advisory Services first reported a position in Elevance Health in Q2 2024 and has held it in 4 quarters since.
  • Capital Asset Advisory Services's Elevance Health position peaked at $337K in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Capital Asset Advisory Services's 13F filing for Q1 2026, filed 24 Apr 2026.